WHO vaccine-preventable diseases: monitoring system. 2016 global summary

Last updated 15-July-2016 (15-July-2016)
Next overall update Fall 2016
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 5'4101 Infant (under 12 months) mortality rate: 112
GDP / capita (US$): 14'6611 Child (under 5 years) mortality rate: 122

Population data in thousands3

  2015  2014  2013  2012  2011  2000  1990  1980 
Total population 67'959  67'726  67'451  67'164  66'903  62'693  56'583  47'385 
Births 715  730  745  759  772  905  1'081  1'254 
Surviving infants 707  722  737  751  763  888  1'049  1'196 
Pop. less than 5 years 3'799  3'846  3'880  3'912  3'952  4'654  5'354  6'159 
Pop. less than 15 years 12'036  12'170  12'301  12'443  12'608  15'031  17'094  18'687 
Female 15-49 years 17'766  17'924  18'059  18'177  18'289  18'244  15'774  11'657 

Number of reported cases

(Click for retrospective incidence data for Thailand)
Diphtheria
ChartChart
  19  19  28  63  28  15  58  1'918 
Japanese encephalitis
ChartChart
  23  31  59  54  52 
Measles
ChartChart ChartChart
  154  2'641  5'197  3'156  4'074  29'244  16'795 
Mumps
ChartChart
  3'121  3'704  5'907  7'431  10'077  6'527 
Pertussis
ChartChart
  51  14  24  14  12  93  487  4'820 
Polio*
ChartChart
  20  300 
Rubella
ChartChart
  240  152  539  493  517  1'136 
Rubella (CRS)
ChartChart
 
Tetanus (neonatal)
ChartChart
  17  212  664 
Tetanus (total)**
ChartChart
  76  81  126  105  110  220  813  1'818 
Yellow fever
ChartChart
 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For desagregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Thailand)
Vaccine year result method % card seen                                                
BCG 2012  100  EPI     99*  99*  99*  99*  99*  99  99*  68 
DTP1 2011  97  MICS   82  99*  99*  99*  99*  99*  99 
DTP3 2012  99  EPI     99  99  99  99  99  97  85  49 
DTP4          98  98 
IPV1         
HepB_BD          99*  99*  99*  99*  99*  99 
HepB3 2012  99  EPI     99  99  99  98  98  95 
Hib3         
JapEnc          92  92  92  95  95 
MCV1          99  99  99  98  98  94  70 
MCV2          95  94  94  91  91  99* 
PCV1         
PCV3         
Pol3 2012  99  EPI     99  99  99  99  99  97  89  19 
Rota1         
RotaC         
Rubella1          99  99  99  98 
TT2plus 2011  71  MICS   82  98  98  98  97  97  90  76  28 
PAB         
VAD1         
YFV         
° indicates that more than 1 survey occurred that year.  * indicates the country reported above 100% coverage.

  Next update: Mid July 2017

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Thailand)
BCG
ChartChart
  99  99  99  99  99  99  99  68 
DTP1
ChartChart
  99  99  99  99  99  98  97  73 
DTP3
ChartChart
  99  99  99  99  99  97  92  49 
HepB3
ChartChart
  99  99  99  98  98  95 
HepB_BD
ChartChart
  99  99  99  99  99  99 
Hib3
ChartChart
 
IPV1
ChartChart
 
MCV1
ChartChart
  99  99  99  98  98  94  80 
MCV2
ChartChart
  95  94  94  91  91  99 
PAB
ChartChart
  95  95  91  91  91  85  75  25 
PCV3
ChartChart
 
Pol3
ChartChart
  99  99  99  99  99  97  92  19 
RCV1
ChartChart
  99  99  99  98  98  94 
RotaC
ChartChart
 

Number of districts in the country 928  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
 
   
/
|
|
\
Greater or equal to 90%
From 80 to 89%
From 50 to 79%
Less than 50%
Proportion of districts
not reporting DTP3 coverage
100
DTP3 reported coverageDTP3 reported coverage

Immunization Schedule (2015 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
CHOLERA No Traveller requirement in some countries
DTwP 1.5, 4 years; Yes
DTwPHep 2, 4, 6 months; Yes
HPV Girls grade 5, 6; No Pilot project in Pranakhonsri Ayuthaya Province
HepB birth; 1 month; Yes The dose at 1 month is especially give to newborn from HB carrier mother
IPV Yes
Influenza 6 months - 2 years; >65 years; Yes Health care worker, elderly and chronic disease patient (COPD, asthma, CVS, chronic renal failure, Cancer patient during chemotherapy and DM)
JapEnc 1.5 (x2), 2.5 years; Yes JE_Live use in the pilot project in 29 Provinces and will be expended the whole country in 2016.
MMR 9 months; 2.5 years; Yes school children grade 1
MR 9 months; 2.5 years; Yes in case of shortage of MMR
MenACWY No Traveller requirement in some countries
OPV 2, 4, 6 months; 1.5, 4 years; Yes
Rotavirus 2, 4 months; No in Sukhothai Province
Td Yes All school children in grade VI (average age of 12 years old) and Pregnant Women (no. of dose given depend on vaccine history if never : 1st contact +1 month, +6 months)
YF Yes Traveller to 32 countries in Africa and 13 countries in South America

Immunizaton indicators

Indicator Expected answer 2015  2014  2013  2012  2011  2010  2009 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2013-2016  2013-2016  2013-2016    2009-2012  2009-2012  2009-2012 
Nº of districts with microplans that include activities to raise immunization coverage number 928  928  928  928       

System performance

Total Nº districts in country number 928  928  928  927  931  926  926 
Nº districts with measles (MCV1) coverage >=95% number           NA  NA 
% of districts with MCV1 coverage >=95% From 0 to 100%              

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes  Yes  Yes  Yes   
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

Immunization expenditure financed, using Government funds? From 0 to 100%   100      100  95  100 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes   

Sources

 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2015 revision". New York, 2016.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.